In the immunohistochemical (IHC) assay, the CH (OVA+poly I:C)-NP-treated group showed a significantly greater population of CD8+ T cells in tumor tissue as compared to the other groups (*p < 0.001). The gene discussed is CD8A; the disease is neoplasm.